NorthStar Asset Management (Pennsylvania)’s Pfizer PFE Stock Holding History

NorthStar Asset Management (Pennsylvania)’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$353K	Sell	12,574 -1,775	-12%	-$47.3K	0.08%	113
2025 Q4	$357K	Sell	14,349 -675	-4%	-$17K	0.08%	116
2025 Q3	$383K	Sell	15,024 -3,600	-19%	-$88.9K	0.08%	115
2025 Q2	$451K	Sell	18,624 -550	-3%	-$12.8K	0.1%	103
2025 Q1	$486K	Sell	19,174 -2,038	-10%	-$53.3K	0.12%	91
2024 Q4	$563K	Sell	21,212 -1,295	-6%	-$35.1K	0.13%	84
2024 Q3	$651K	Sell	22,507 -3,450	-13%	-$101K	0.15%	81
2024 Q2	$726K	Sell	25,957 -260	-1%	-$7.16K	0.18%	74
2024 Q1	$728K	Sell	26,217 -275	-1%	-$7.63K	0.18%	78
2023 Q4	$763K	Sell	26,492 -1,150	-4%	-$34.8K	0.2%	76
2023 Q3	$917K	Buy	27,642 +1,700	+7%	+$60.1K	0.26%	65
2023 Q2	$952K	Sell	25,942 -500	-2%	-$19.5K	0.26%	67
2023 Q1	$1.08M	Buy	26,442 +650	+3%	+$28.1K	0.32%	63
2022 Q4	$1.32M	Sell	25,792 -575	-2%	-$27.6K	0.42%	53
2022 Q3	$1.15M	Buy	26,367 +275	+1%	+$13.4K	0.38%	54
2022 Q2	$1.37M	Hold	26,092	–	–	0.43%	56
2022 Q1	$1.35M	Buy	26,092 +200	+0.8%	+$10.4K	0.35%	61
2021 Q4	$1.53M	Buy	25,892 +175	+0.7%	+$8.67K	0.36%	58
2021 Q3	$1.11M	Buy	25,717 +250	+1%	+$11.1K	0.29%	67
2021 Q2	$997K	Sell	25,467 -500	-2%	-$19.4K	0.26%	71
2021 Q1	$941K	Buy	25,967 +100	+0.4%	+$3.55K	0.27%	72
2020 Q4	$952K	Sell	25,867 -2,371	-8%	-$87K	0.27%	69
2020 Q3	$983K	Hold	28,238	–	–	0.31%	65
2020 Q2	$876K	Hold	28,238	–	–	0.31%	63
2020 Q1	$874K	Buy	28,238 +527	+2%	+$18K	0.4%	57
2019 Q4	$1.03M	Sell	27,711 -2,498	-8%	-$89K	0.39%	59
2019 Q3	$1.03M	Sell	30,209 -263	-0.9%	-$9.56K	0.4%	57
2019 Q2	$1.25M	Sell	30,472 -106	-0.3%	-$4.21K	0.49%	54
2019 Q1	$1.23M	Buy	30,578 +3,151	+11%	+$126K	0.5%	52
2018 Q4	$1.14M	Sell	27,427 -316	-1%	-$13.1K	0.53%	53
2018 Q3	$1.16M	Sell	27,743 -1,900	-6%	-$73.1K	0.45%	61
2018 Q2	$1.02M	Sell	29,643 -1,628	-5%	-$55.6K	0.42%	61
2018 Q1	$1.05M	Sell	31,271 -1,054	-3%	-$36.2K	0.44%	60
2017 Q4	$1.11M	Buy	32,325 +948	+3%	+$32.3K	0.46%	60
2017 Q3	$1.06M	Sell	31,377 -68	-0.2%	-$2.19K	0.47%	62
2017 Q2	$1M	Sell	31,445 -2,652	-8%	-$83.6K	0.45%	61
2017 Q1	$1.11M	Hold	34,097	–	–	0.49%	55
2016 Q4	$1.05M	Sell	34,097 -474	-1%	-$14.5K	0.47%	56
2016 Q3	$1.11M	Hold	34,571	–	–	0.46%	53
2016 Q2	$1.16M	Hold	34,571	–	–	0.48%	49
2016 Q1	$972K	Sell	34,571 -4,077	-11%	-$116K	0.41%	54
2015 Q4	$1.18M	Hold	38,648	–	–	0.5%	48
2015 Q3	$1.15M	Sell	38,648 -1,415	-4%	-$45.4K	0.52%	49
2015 Q2	$1.27M	Buy	40,063 +2,477	+7%	+$80.7K	0.53%	49
2015 Q1	$1.24M	Sell	37,586 -5,756	-13%	-$183K	0.53%	47
2014 Q4	$1.28M	Sell	43,342 -399	-0.9%	-$11.4K	0.56%	45
2014 Q3	$1.23M	Hold	43,741	–	–	0.53%	45
2014 Q2	$1.23M	Sell	43,741 -2,108	-5%	-$60.1K	0.52%	44
2014 Q1	$1.4M	Hold	45,849	–	–	0.64%	42
2013 Q4	$1.33M	Sell	45,849 -1,460	-3%	-$42.5K	0.62%	39
2013 Q3	$1.29M	Buy	47,309 +1,415	+3%	+$38.5K	0.66%	37
2013 Q2	$1.22M	Buy	+45,894	New	+$1.27M	0.52%	50

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

NorthStar Asset Management (Pennsylvania)'s PFE Position: Q1 2026 in Review

NorthStar Asset Management (Pennsylvania) reduced its Pfizer (PFE) stake by 12% in Q1 2026, selling an estimated $47.3K and leaving 12,574 shares worth $353K. The position accounts for 0.08% of the portfolio, ranked #113.

NorthStar Asset Management (Pennsylvania) first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.53M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

NorthStar Asset Management (Pennsylvania) held 12,574 shares of Pfizer worth $353K as of Q1 2026.
NorthStar Asset Management (Pennsylvania) sold 1,775 Pfizer shares in Q1 2026, an estimated $47.3K.
Pfizer made up 0.08% of NorthStar Asset Management (Pennsylvania)'s portfolio in Q1 2026, its #113 holding.
NorthStar Asset Management (Pennsylvania) first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
NorthStar Asset Management (Pennsylvania)'s Pfizer position peaked at $1.53M in Q4 2021.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on NorthStar Asset Management (Pennsylvania)'s 13F filing for Q1 2026, filed 23 Apr 2026.